The sales for the March 2026 quarter moved down to Rs. 64.02 millions as compared to Rs. 84.26 millions during the year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -18.83 millions as compared to Net Loss of Rs. -24.80 millions of corresponding quarter ended March 2025 Operating profit Margin for the quarter ended March 2026 improved to 5.47% as compared to -11.77% of corresponding quarter ended March 2025

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	64.02	84.26	-24.02	256.44	327.49	-21.70	256.44	327.49	-21.70
Other Income	9.90	0.11	8900.00	59.68	19.72	202.64	59.68	19.72	202.64
PBIDT	5.47	-11.77	-146.47	30.03	-15.07	-299.27	30.03	-15.07	-299.27
Interest	3.19	5.97	-46.57	21.71	18.87	15.05	21.71	18.87	15.05
PBDT	-12.66	-17.74	-28.64	-9.58	-33.94	-71.77	-9.58	-33.94	-71.77
Depreciation	6.60	6.64	-0.60	26.88	26.43	1.70	26.88	26.43	1.70
PBT	-19.26	-24.38	-21.00	-36.46	-60.37	-39.61	-36.46	-60.37	-39.61
TAX	-0.43	0.42	-202.38	-0.77	0.72	-206.94	-0.77	0.72	-206.94
Deferred Tax	-0.43	0.42	-202.38	-0.77	0.72	-206.94	-0.77	0.72	-206.94
PAT	-18.83	-24.80	-24.07	-35.69	-61.09	-41.58	-35.69	-61.09	-41.58
Equity	50.41	50.41	0.00	50.41	50.41	0.00	50.41	50.41	0.00
PBIDTM(%)	8.54	-13.97	-161.17	11.71	-4.60	-354.48	11.71	-4.60	-354.48

GKB Ophthalmics Ltd.